Aytu BioScience Inc. | Cash Flow
Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
61.70
7,723.40
28,180.10
22,508.30
10,187.90
Depreciation, Depletion & Amortization
4.80
240.20
874.80
4,364.70
2,591.30
Other Funds
-
47.50
5,200.00
7,607.50
-
Funds from Operations
37.10
6,489.20
12,449.30
12,788.10
15,221.50
Changes in Working Capital
1.70
145.00
1,791.90
1,041.60
718.80
Net Operating Cash Flow
38.70
6,634.20
10,657.40
13,829.70
15,940.30
Capital Expenditures
-
-
3,292.90
6,861.60
474.70
Purchase/Sale of Investments
-
1,000.00
2,013.00
979.80
-
Net Investing Cash Flow
-
1,004.90
5,303.90
3,534.50
484.30
Issuance/Reduction of Debt, Net
21.50
-
4,846.90
-
-
Net Financing Cash Flow
39.20
12,352.50
16,662.50
10,187.50
22,659.60
Net Change in Cash
0.50
4,713.40
701.10
7,176.60
6,235.00
Free Cash Flow
38.70
6,634.20
10,910.40
13,941.30
16,015.00
Deferred Taxes & Investment Tax Credit
-
23.90
-
-
-
Other Sources
-
-
2.00
2,363.30
-
Change in Capital Stock
17.70
12,400.00
6,615.60
2,580.10
22,659.60
Other Uses
-
4.90
-
16.10
9.60
About Aytu BioScience
View Profile
